» Articles » PMID: 19128999

Sonolysis of Levodopa and Paracetamol in Aqueous Solutions

Overview
Specialty Radiology
Date 2009 Jan 9
PMID 19128999
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Pharmaceutical products are often present in wastewater treatment effluents, rivers, lakes and, more rarely, in groundwater. The advanced oxidation methods, like ultrasound, find a promising future in the area of wastewater treatment. The aim of this paper is to evaluate the influence of several parameters of the ultrasound process on the degradation of paracetamol, a widely used non-steroidal anti-inflammatory recalcitrant drug found in water and levodopa, the most frequently prescribed drug for the treatment of Parkinson disease. Experiments were carried out at 574, 860 and 1134kHz of ultrasonic frequency with horn-type sonicator and actual power values of 9, 17, 22 and 32W at 20 degrees C. Initial concentrations of 25, 50, 100 and 150mgL(-1) of both products were used. Treatment efficiency was assessed following changes in pharmaceuticals concentration and chemical oxygen demand. The sonochemical degradation of both products follows a pseudo-first-order reaction kinetics. Complete removal of pharmaceuticals was achieved in some cases but some dissolved organic carbon remains in solution showing that long lived intermediates were recalcitrant to ultrasound irradiation. Pollutants conversion and COD removal were found to decrease with increasing the initial solute concentration and decreasing power. The best results were obtained with 574kHz frequency. Investigations using 1-butanol as radical scavenger and H(2)O(2) as promoter revealed that pollutants degradation proceeds principally through radical reactions, although some differences were observed between both molecules. Addition of H(2)O(2) had a positive effect on degradation rate, but the optimum concentration of hydrogen peroxide depends on the pollutant.

Citing Articles

A fundamental study on the degradation of paracetamol under single- and dual-frequency ultrasound.

Zare M, Alfonso-Muniozguren P, Bussemaker M, Sears P, Serna-Galvis E, Torres-Palma R Ultrason Sonochem. 2023; 94:106320.

PMID: 36780809 PMC: 9925978. DOI: 10.1016/j.ultsonch.2023.106320.


Development of Jelly Loaded with Nanogel Containing Natural L-Dopa from Seed Extract for Neuroprotection in Parkinson's Disease.

Chittasupho C, Tadtong S, Vorarat S, Imaram W, Athikomkulchai S, Samee W Pharmaceutics. 2022; 14(5).

PMID: 35631666 PMC: 9147856. DOI: 10.3390/pharmaceutics14051079.


Synergistic effect of sonication on photocatalytic oxidation of pharmaceutical drug carbamazepine.

Yentur G, Dukkanci M Ultrason Sonochem. 2021; 78:105749.

PMID: 34520962 PMC: 8441083. DOI: 10.1016/j.ultsonch.2021.105749.


A review on pharmaceuticals removal from waters by single and combined biological, membrane filtration and ultrasound systems.

Alfonso-Muniozguren P, Serna-Galvis E, Bussemaker M, Torres-Palma R, Lee J Ultrason Sonochem. 2021; 76:105656.

PMID: 34274706 PMC: 8319449. DOI: 10.1016/j.ultsonch.2021.105656.


Pharmaceuticals Market, Consumption Trends and Disease Incidence Are Not Driving the Pharmaceutical Research on Water and Wastewater.

Gonzalez Pena O, Lopez Zavala M, Cabral Ruelas H Int J Environ Res Public Health. 2021; 18(5).

PMID: 33806343 PMC: 7967517. DOI: 10.3390/ijerph18052532.